This week, NIC-S co-exhibited with DS Group at the World Tobacco Middle East, held at the Dubai World Trade Centre. The event, renowned for bringing together leading professionals in the tobacco industry, provided an excellent platform to showcase NIC-S and connect with industry peers. We were thrilled to engage with visitors and to demonstrate our […]
Enorama Pharma is proud to announce that NIC-S has been honored with the distinguished 2024 Best New Products Award in the “Other Tobacco Nicotine Products: Smokeless” category. This award, presented by Convenience Store News, recognizes the top new convenience store products of the year, judged on criteria such as value, convenience, appearance, packaging, taste, and […]
US industry-leading publication, Convenience Store News, presents our nicotine pouches NIC-S, effectively highlighting their unique selling points for both consumers and retailers. The article also shows the distinct branding that sets NIC-S apart in the market segment, making it particularly attractive to retailers seeking differentiation. This combination of well-presented content and authoritative publishing makes the […]
Our nicotine pouch NIC-S is now available in more than 700 stores across 21 states. Here are a few examples of how NIC-S is displayed in some of the stores.
We’re thrilled to announce that NIC-S, our premium nicotine pouch, is now available for purchase online at Prilla! This is made possible through our continued collaboration with Prilla, a leading online platform in the USA with whom we have previously had a successful partnership. Prilla shares our commitment to quality and customer satisfaction, making them […]
NIC-S is presented and advertised in the latest newsletter from CStore, the primary source for product updates tailored to small and mid-sized convenience retail chains. See the newsletter
The European Patent Office (EPO) has now granted Enorama’s patent for a nicotine-containing chewing gum composition and manufacturing method. The decision follows EPO’s earlier announcement of its intention to approve the patent application. This marks a significant milestone for Enorama and our product development in the nicotine replacement therapy field.
After 3 years in the neighbourhood of “Västra Hamnen”, we have relocated back to the city center. Our rent and square footage had become too high/large. Now we have premises that better suits our company – whilst there is still room for us to grow.
The analysis of NIC-S went well, the products have been released and are now delivered to our distributor, Premier Manufacturing Inc., in the USA.
To comply with our PMTA application and to ensure high quality, NIC-S is analysed before being released from the factory. Once the analysis results are available and the products are released, they are prepared for shipment to the USA.